synlogictx.com (SYBX) Company Long-Term Loans and Borrowings

Synlogic - graphic logo of issuer SYBX

Synlogic, Inc. (SYBX) is currently experiencing a period of technological stagnation and resource reallocation following the abandonment of its biotherapeutic projects. The company's operations are further complicated by the disruption of logistics chains and restrictions on international data exchange. The price trend reflected below on the GURU.Markets platform, where the metric stands at 0.00, highlights a critical liquidity shortage and the threat of business closure due to the cessation of primary drug development.

SYBX Synlogic Inc.: Company Long-Term Debts in the range 07/04/2022 - 01/24/2026

Synlogic - analytical breakdowns and key metrics (SYBX)

- price and consensus price forecast:
Stock Price Synlogic Inc.|SYBX - Price Target Chart
- market capitalization data:
Market Value Synlogic|SYBX - Total Company Value
- book capitalization data:
Accounting Value per Share Synlogic|SYBX - Book Capitalization|Market Capitalization to Book Value Ratio synlogictx.com|SYBX - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Synlogic, Inc.|SYBX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Synlogic Inc.|SYBX - Company Aggregate Debts|Debts to Book Value Synlogic|SYBX - Company Long-Term Liabilities|Amount of Current Liabilities Synlogic
Fundamental valuation:SYBX - Synlogic, Inc.
Manufactured products of Synlogic Corp

Amid the complete cessation of operating activities and the liquidation of assets at Synlogic, Inc. (SYBX), the company's long-term debt becomes a critical indicator of solvency during the winding-down process. This metric captures the dynamics of borrowed capital and sensitivity to interest rate shocks, allowing investors to assess real default risks and the consistency of obligation repayments during the period of financial decline through an analysis of the company's long-term debt.

Competitors of Synlogic, Inc.

ascendispharma.com - Company Long-Term Debts|Company Long-Term Debt Madrigal Pharmaceuticals, Inc. (MDGL)|CORT: Company Long-Term Loans and Borrowings|RYTM (Rhythm Pharmaceuticals Inc) - Company Long-Term Debt|Akero Corp (AKRO) - Company Long-Term Liabilities|MTSR (Metsera Inc) - Company Long-Term Debts|Company Long-Term Debts moonlaketx.com (MLTX)|Crinetics (CRNX) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings NAMS (NewAmsterdam Pharma Company)|Soleno - Company Long-Term Debt|Company Long-Term Liabilities Amicus Corp FOLD|ETNB (89bio, Inc.) - Company Long-Term Debts|agios.com (AGIO) - Long-Term Debt|GPCR - Company Long-Term Liabilities|MiMedx Group Inc (MDXG) - Amount of Long-Term Liabilities|RZLT (Rezolute Corp) - Company Long-Term Debts|Company Long-Term Debts Lexicon Corp|Company Long-Term Debts MBX Biosciences Inc (MBX)|Company Long-Term Debt ALT (altimmune.com)|AARD: Company Long-Term Debt|Sagimet Biosciences, Inc. - Long-Term Debt|BIOA - Company Long-Term Debt|BMEA - Company Long-Term Debt|quincetx.com - Company Long-Term Debts|GUTS (fractyl.com) - Long-Term Debt Volume|VTVT: Company Long-Term Debt|Long-Term Debt Volume ATPC|Company Long-Term Debt PLUR (Pluri Inc.)|Company Long-Term Liabilities LPCN (Lipocine Corporation)|Company Long-Term Debt MTNB|SPRB - Long-Term Debt Volume|GLTO (Galecto) - Company Long-Term Liabilities|CTCX: Long-Term Debt|Company Long-Term Debt Lumos Pharma Corp|ONVO (Organovo Corp) - Company Long-Term Indebtedness|Company Long-Term Debt Radius Recycling, Inc.